Immunotherapies including cancer vaccines modulate (stimulate) the innate and adaptive immune systems at cellular level, whereas modulation of tumor microenvironment (TME) can cause the hindrance for CD8+ T cells on suppression of immune system and allowing the active targeting [221, 223]. Here, CD8A is linked to neoplasm.